The safety profile and antiviral activity of the combination of stavudine, didanosine, and nelfinavir in patients with HIV infection

This publication has 6 references indexed in Scilit:

• Activities of the human immunodeficiency virus type 1 (HIV-1) protease inhibitor nelfinavir mesylate in combination with reverse transcriptase and protease inhibitors against acute HIV-1 infection in vitro
  Antimicrobial Agents and Chemotherapy, 1997
• A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less
  New England Journal of Medicine, 1997
• Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel
  Published by American Medical Association (AMA) ,1997
• British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals
  The Lancet, 1997
• Quantitation of didanosine in human plasma and urine by high-performance liquid chromatography
  Journal of Chromatography B: Biomedical Sciences and Applications, 1990
• Evaluation of patients with advanced cancer using the karnofsky performance status
  Cancer, 1980